Tag: Innovations
-
The Cloudflare Blog: Connect any React application to an MCP server in three lines of code
Source URL: https://blog.cloudflare.com/connect-any-react-application-to-an-mcp-server-in-three-lines-of-code/ Source: The Cloudflare Blog Title: Connect any React application to an MCP server in three lines of code Feedly Summary: We’re open-sourcing use-mcp, a React library that connects to any MCP server in just 3 lines of code, as well as our AI Playground, a complete chat interface that can connect to…
-
The Register: MiniMax M1 model claims Chinese LLM crown from DeepSeek – plus it’s true open-source
Source URL: https://www.theregister.com/2025/06/17/minimax_m1_model_chinese_llm/ Source: The Register Title: MiniMax M1 model claims Chinese LLM crown from DeepSeek – plus it’s true open-source Feedly Summary: China’s ‘little dragons’ pose big challenge to US AI firms MiniMax, an AI firm based in Shanghai, has released an open-source reasoning model that challenges Chinese rival DeepSeek and US-based Anthropic, OpenAI,…
-
AWS News Blog: AWS Weekly Roundup: AWS re:Inforce 2025, AWS WAF, AWS Control Tower, and more (June 16, 2025)
Source URL: https://aws.amazon.com/blogs/aws/aws-weekly-roundup-aws-reinforce-2025-aws-waf-aws-control-tower-and-more-june-16-2025/ Source: AWS News Blog Title: AWS Weekly Roundup: AWS re:Inforce 2025, AWS WAF, AWS Control Tower, and more (June 16, 2025) Feedly Summary: Today marks the start of AWS re:Inforce 2025, where security professionals are gathering for three days of technical learning sessions, workshops, and demonstrations. This security-focused conference brings together AWS…
-
Slashdot: FDA To Use AI In Drug Approvals To ‘Radically Increase Efficiency’
Source URL: https://science.slashdot.org/story/25/06/11/015216/fda-to-use-ai-in-drug-approvals-to-radically-increase-efficiency?utm_source=rss1.0mainlinkanon&utm_medium=feed Source: Slashdot Title: FDA To Use AI In Drug Approvals To ‘Radically Increase Efficiency’ Feedly Summary: AI Summary and Description: Yes Summary: The FDA’s new strategy involves utilizing AI, specifically a large-language model named Elsa, to enhance the efficiency of drug and device approval processes. While promising, some limitations and challenges remain…